Sign Up Today and Learn More About Vita Therapeutics Stock
Invest in or calculate the value of your shares in Vita Therapeutics or other pre-IPO companies through EquityZen's platform.
Vita Therapeutics Stock (VIAT)
Vita Therapeutics is a cell engineering company that develops life-transformative treatments.
About Vita Therapeutics Stock
Founded
2018
Headquarters
Baltimore, MD, US
Industries
Software, Artificial Intelligence, Data and Analytics
Vita Therapeutics Press Mentions
Stay in the know about the latest news on Vita Therapeutics
The Role of Community College in Shaping Your Biotech Career
biobuzz • Jan 19, 2024
Lululemon Founder Chip Wilson Races to Find Muscular ...
bloomberg • Dec 20, 2023
First preclinical results for VTA-100 reported by Vita Therapeutics
bioworld • Jun 21, 2023
Money Moves: Baltimore’s Vita Therapeutics raised a $31M Series B
bit • Oct 16, 2022
Vita Therapeutics Closes $31M Series B Financing.
vcnewsdaily • Oct 13, 2022
Vita Therapeutics Management
Leadership team at Vita Therapeutics
Co-Founder and CEO
Douglas Falk
Chief Scientific Officer
Peter Andersen
Join now and verify your accreditation status to gain access to:
- Vita Therapeutics current valuation
- Vita Therapeutics stock price
- Available deals in Vita Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Vita Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Vita Therapeutics through EquityZen funds. These investments are made available by existing Vita Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Vita Therapeutics stock?
Shareholders can sell their Vita Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
